Tiotech

Tiotech company information, Employees & Contact Information

Explore related pages

Related company profiles:

We enable the green shift to happen in new markets! TioTech is a Norwegian producer of titania (TiO2) nanomaterials and a developer of titania-based technology. We know how to optimise the production process and properties of titania nanoparticles. After successfully developing and commercialising a series of photocatalytic surface treatment products (www.joma-int.com), we are directing our R&D efforts towards a new area; the use of titania as anode-material in Lithium-ion batteries (LIB). A battery with our material on the anode will charge faster, last longer, be safer and tolerate temperature variation better than conventional batteries which have graphite on the anode, and outcompete LTO-batteries on capacity. The development work takes place in our in-house laboratory in Bergen, where our dedicated team play around with titania, giving life to innovative solutions.

Company Details

Employees
13
Founded
-
Address
Heiane 2b, Nyborg,norway
Industry
Nanotechnology Research
NAICS
Research and Development in Nanotechnology
HQ
Bergen, Vestland
Looking for a particular Tiotech employee's phone or email?

Tiotech Questions

News

Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs - Fierce Biotech

Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs Fierce Biotech

BRAIN Biotech AG Appoints Johan Jansen-Storbacka as Executive Vice President of the BRAINBiocatalysts' Enzyme Products Business - Yahoo Finance

BRAIN Biotech AG Appoints Johan Jansen-Storbacka as Executive Vice President of the BRAINBiocatalysts' Enzyme Products Business Yahoo Finance

Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies - GlobeNewswire

Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies GlobeNewswire

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors - Biotech Newswire

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors Biotech Newswire

$18M Financing Deal: Purple Biotech Prices Public Offering with $1.00 Warrants for Cancer Drug Development - Stock Titan

$18M Financing Deal: Purple Biotech Prices Public Offering with $1.00 Warrants for Cancer Drug Development Stock Titan

Concentra extends biotech shopping spree by collecting Cargo - Fierce Biotech

Concentra extends biotech shopping spree by collecting Cargo Fierce Biotech

Acticor Biotech Announces that the Court Judgment Has Been Postponed Until January 2, 2025 - Business Wire

Acticor Biotech Announces that the Court Judgment Has Been Postponed Until January 2, 2025 Business Wire

Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2 - Yahoo Finance

Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2 Yahoo Finance

Clinical-Stage Cancer Drug Developer Purple Biotech to Present at Major Healthcare Conference - Stock Titan

Clinical-Stage Cancer Drug Developer Purple Biotech to Present at Major Healthcare Conference Stock Titan

Sanofi-backed SpliceBio secures $135M series B for eye disease gene therapy trials - Fierce Biotech

Sanofi-backed SpliceBio secures $135M series B for eye disease gene therapy trials Fierce Biotech

Purple Biotech Announces Pricing of Up To $18 Million Public Offering - Yahoo Finance

Purple Biotech Announces Pricing of Up To $18 Million Public Offering Yahoo Finance

Verve's 2nd swing at PCSK9 editing yields clean safety profile, teeing up Lilly opt-in decision - Fierce Biotech

Verve's 2nd swing at PCSK9 editing yields clean safety profile, teeing up Lilly opt-in decision Fierce Biotech

RFK Jr. cuts 4,700 FDA and NIH jobs as HHS eliminates 'an entire alphabet soup of departments' - Fierce Biotech

RFK Jr. cuts 4,700 FDA and NIH jobs as HHS eliminates 'an entire alphabet soup of departments' Fierce Biotech

Fierce Biotech Layoff Tracker 2025: Alector halves staff; Galapagos axes cell therapy unit - Fierce Biotech

Fierce Biotech Layoff Tracker 2025: Alector halves staff; Galapagos axes cell therapy unit Fierce Biotech

Fierce Biotech Fundraising Tracker '25: Hemab closes $157M series C; Electra shines with $183M - Fierce Biotech

Fierce Biotech Fundraising Tracker '25: Hemab closes $157M series C; Electra shines with $183M Fierce Biotech

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers Fierce Biotech

Biomea's diabetes drug improves glucose control 3 months after FDA hold lifted - Fierce Biotech

Biomea's diabetes drug improves glucose control 3 months after FDA hold lifted Fierce Biotech

Kronos shelves sole remaining clinical asset over neurological side effects - Fierce Biotech

Kronos shelves sole remaining clinical asset over neurological side effects Fierce Biotech

MacroGenics pauses work on vobra duo ADC pending mature survival data - Fierce Biotech

MacroGenics pauses work on vobra duo ADC pending mature survival data Fierce Biotech

Biotech faces a reckoning: 'We've lost our luster in cell therapies' - Fierce Biotech

Biotech faces a reckoning: 'We've lost our luster in cell therapies' Fierce Biotech

Kelun-Biotech Announces Approximately US$250 Million Placement - PR Newswire

Kelun-Biotech Announces Approximately US$250 Million Placement PR Newswire

The end of eFFECTOR Therapeutics: Oncology biotech winds down after midstage fail - Fierce Biotech

The end of eFFECTOR Therapeutics: Oncology biotech winds down after midstage fail Fierce Biotech

CHANGING THE FUTURE OF BIOTECH - NEOM

CHANGING THE FUTURE OF BIOTECH NEOM

AstraZeneca plants an EGFR tree with Pinetree deal worth $45M - Fierce Biotech

AstraZeneca plants an EGFR tree with Pinetree deal worth $45M Fierce Biotech

Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission - Fierce Biotech

Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission Fierce Biotech

AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies - Fierce Biotech

AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies Fierce Biotech

Introducing Fierce Biotech's 2023 Fierce 15 - Fierce Biotech

Introducing Fierce Biotech's 2023 Fierce 15 Fierce Biotech

Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M - Fierce Biotech

Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M Fierce Biotech

Purple Biotech Reports First Quarter 2025 Financial Results - Yahoo Finance

Purple Biotech Reports First Quarter 2025 Financial Results Yahoo Finance

Purple Biotech CEO Issues Letter to Shareholders - GlobeNewswire

Purple Biotech CEO Issues Letter to Shareholders GlobeNewswire

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire

Fierce Biotech's 2021 Fierce 15 - Fierce Biotech

Fierce Biotech's 2021 Fierce 15 Fierce Biotech

Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups - Yahoo Finance

Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups Yahoo Finance

Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC - PR Newswire

Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC PR Newswire

The top biotech hubs in 2022 - Fierce Biotech

The top biotech hubs in 2022 Fierce Biotech

DolCas Biotech Marine Collagen Boosts the Morning Coffee Break - PR Newswire

DolCas Biotech Marine Collagen Boosts the Morning Coffee Break PR Newswire

Fierce Biotech's 2022 Fierce 15 - Fierce Biotech

Fierce Biotech's 2022 Fierce 15 Fierce Biotech

Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai - Yahoo Finance

Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai Yahoo Finance

Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire

Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results GlobeNewswire

$18M Financing: Purple Biotech Secures $6M Public Offering Plus $12M in Short-Term Warrant Potential - Stock Titan

$18M Financing: Purple Biotech Secures $6M Public Offering Plus $12M in Short-Term Warrant Potential Stock Titan

Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer - Yahoo Finance

Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer Yahoo Finance

Purple Biotech's Cancer Drug Achieves 5x Better Response Rate in Pancreatic Cancer Patients with Biomarkers - Stock Titan

Purple Biotech's Cancer Drug Achieves 5x Better Response Rate in Pancreatic Cancer Patients with Biomarkers Stock Titan

26,000 Human Transcriptomes: Purple Biotech's Novel Cancer Drug Shows Promise in Resistant Tumors - Stock Titan

26,000 Human Transcriptomes: Purple Biotech's Novel Cancer Drug Shows Promise in Resistant Tumors Stock Titan

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer - GlobeNewswire

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer GlobeNewswire

Purple Biotech Appoints Shai Lankry as Chief Financial Officer - GlobeNewswire

Purple Biotech Appoints Shai Lankry as Chief Financial Officer GlobeNewswire

Hal Barron quits GSK to take CEO post at $3B biotech startup, leaving Wood to finish what he began - Fierce Biotech

Hal Barron quits GSK to take CEO post at $3B biotech startup, leaving Wood to finish what he began Fierce Biotech

SIRION Biotech - Pharmaceutical Technology

SIRION Biotech Pharmaceutical Technology

Purple Biotech Announces Research Collaboration with the - GlobeNewswire

Purple Biotech Announces Research Collaboration with the GlobeNewswire

Breakthrough 1-5pM Efficacy: Purple Biotech's Novel Triple-Action Cancer Antibody Shows Promise in TNBC - Stock Titan

Breakthrough 1-5pM Efficacy: Purple Biotech's Novel Triple-Action Cancer Antibody Shows Promise in TNBC Stock Titan

Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial - GlobeNewswire

Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial GlobeNewswire

Purple Biotech Granted New U.S. Patent for NT219 in - GlobeNewswire

Purple Biotech Granted New U.S. Patent for NT219 in GlobeNewswire

Purple Biotech Reports Positive Final Results from - GlobeNewswire

Purple Biotech Reports Positive Final Results from GlobeNewswire

VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System - PR Newswire

VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System PR Newswire

ACTICOR BIOTECH: Topline Results of ACTISAVE Phase 2/3 Study in Stroke Treatment - Business Wire

ACTICOR BIOTECH: Topline Results of ACTISAVE Phase 2/3 Study in Stroke Treatment Business Wire

VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System - PR Newswire

VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System PR Newswire

The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions - Business Wire

The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions Business Wire

VERO Biotech's Second Generation GENOSYL® Delivery System (DS) Receives FDA Approval in Anesthesia in the Surgical Suite - PR Newswire

VERO Biotech's Second Generation GENOSYL® Delivery System (DS) Receives FDA Approval in Anesthesia in the Surgical Suite PR Newswire

Purple Biotech Expands Pipeline of First-in-Class - GlobeNewswire

Purple Biotech Expands Pipeline of First-in-Class GlobeNewswire

Evaxion Biotech A/S Announces Executive Management Changes - GlobeNewswire

Evaxion Biotech A/S Announces Executive Management Changes GlobeNewswire

EVAX Stock Price and Chart — NASDAQ:EVAX - TradingView

EVAX Stock Price and Chart — NASDAQ:EVAX TradingView

PPBT Stock Price and Chart — TASE:PPBT - TradingView

PPBT Stock Price and Chart — TASE:PPBT TradingView

PSC Biotech Corporation and PSC Software Announce Acquisition of Three of the Four Largest Pharmaceutical Companies as Customers of Adaptive Compliance Engine™ aka ACE - PR Newswire

PSC Biotech Corporation and PSC Software Announce Acquisition of Three of the Four Largest Pharmaceutical Companies as Customers of Adaptive Compliance Engine™ aka ACE PR Newswire

Top Tiotech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant